Molecular Partners AG
MLLCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $124 | $114 | $185 | $559 |
| - Cash | $64 | $67 | $88 | $72 |
| + Debt | $2 | $4 | $5 | $6 |
| Enterprise Value | $62 | $51 | $102 | $493 |
| Revenue | $5 | $7 | $190 | $9 |
| % Growth | -29.4% | -96.3% | 1,931.7% | – |
| Gross Profit | -$43 | -$41 | $140 | -$46 |
| % Margin | -855.8% | -579.8% | 73.7% | -489.1% |
| EBITDA | -$52 | -$60 | $121 | -$61 |
| % Margin | -1,039.2% | -845.8% | 63.8% | -650.3% |
| Net Income | -$54 | -$62 | $118 | -$64 |
| % Margin | -1,087.4% | -880.7% | 62.2% | -683.7% |
| EPS Diluted | -1.63 | -1.89 | 3.54 | -2.06 |
| % Growth | 13.8% | -153.4% | 271.8% | – |
| Operating Cash Flow | -$59 | -$59 | $119 | -$91 |
| Capital Expenditures | -$1 | -$1 | -$1 | -$1 |
| Free Cash Flow | -$60 | -$60 | $117 | -$92 |